Magnerot (Magnesium Orotate Dihydrate)

Magnerot (magnesium orotate) is used to address conditions related to low magnesium status and to support physiological processes that depend on magnesium.

• Magnesium deficiency: restores normal serum magnesium concentrations and alleviates related symptoms.
• Muscle cramps or spasms: contributes to normal muscle contraction and reduces frequency of cramps.
• Nerve irritability: supports normal nerve impulse transmission, helping to lessen tingling or paresthesia.
• Cardiac arrhythmia risk: aids in maintaining normal cardiac electrophysiology in patients with magnesium‑related disturbances.
• Bone health support: provides magnesium needed for bone mineralization and metabolic balance.

• Magnesium orotate dissociates after oral absorption, releasing magnesium ions that serve as cofactors for ATP‑dependent enzymes, stabilize nucleic acids, and modulate ion channels. The orotate moiety facilitates cellular uptake of magnesium, enhancing intracellular magnesium availability, which is essential for muscle contraction, nerve conduction, and cardiac electrical stability. These actions help normalize metabolic pathways and support electrolyte balance across tissues. Overall, the increased intracellular magnesium improves enzymatic efficiency and stabilizes membrane potentials.

Magnesium orotate may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Diarrhea: loose stools occurring after oral intake.
• Abdominal discomfort: mild stomach pain or cramping.
• Nausea: feeling of sickness without vomiting.
• Flatulence: increased intestinal gas.
• Vomiting: expulsion of stomach contents.
• Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects

• Hypermagnesemia: elevated serum magnesium causing muscle weakness, low blood pressure, or cardiac conduction abnormalities.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing indicating possible anaphylaxis.
• Cardiac arrhythmia: abnormal heart rhythm potentially linked to excessive magnesium levels.

When using Magnerot, certain precautions should be observed to ensure safe and effective therapy.

• Renal function assessment: evaluate kidney performance before initiating therapy.
• Serum magnesium monitoring: check levels periodically to avoid excess.
• Cardiac condition caution: use carefully in patients with heart block or arrhythmias.
• Drug hypersensitivity: discontinue if signs of allergic reaction appear.
• Concomitant medications: review use of other magnesium‑containing products.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Magnesium orotate can affect the absorption or activity of several medicines; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid)

• Tetracycline antibiotics: form complexes that markedly reduce oral absorption.
• Fluoroquinolone antibiotics: chelation decreases bioavailability of both agents.
• Bisphosphonates: concurrent intake impairs bisphosphonate absorption.
• Digoxin: increased magnesium may enhance digoxin effects.

Moderate Interactions (Monitor Closely)

• Calcium supplements: additive effect may raise serum magnesium excessively.
• ACE inhibitors: may increase magnesium levels, requiring periodic monitoring.
• Loop or thiazide diuretics: can alter magnesium balance, necessitating dose adjustment.
• Proton pump inhibitors: may affect magnesium absorption.